Site-Directed Mutagenesis of an Engineered AAV3 Capsid Variant, LK-03, Improves Its Transduction Efficiency in Human Hepatic Cells In Vitro and in a Xenograft Murine Model In Vivo
期刊论文
Site-Directed Mutagenesis of an Engineered AAV3 Capsid Variant, LK-03, Improves Its Transduction Efficiency in Human Hepatic Cells In Vitro and in a Xenograft Murine Model In Vivo